6
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Neurotoxic effects of feline immunodeficiency virus, FIV-PPR

, , , , &
Pages 415-425 | Received 19 Feb 1998, Accepted 20 Mar 1998, Published online: 05 Aug 2009

Reference

  • An S. F., Giometto B., Scaravilli T., Tavolato B., Gray F., Scaravilli F. Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol 1996; 91: 169–173
  • Barks J. D., Sun R., Malinak C., Silverstein F. S. Gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Exp Neurol 1995; 132: 123–133
  • Benos D. J., Hahn B. H., Bubien J. K., Ghosh S. K., Mashburn N. A., Chaikin M. A., Shaw G. M., Benveniste E. N. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994a; 91: 494–498
  • Benos D. J., Hahn B. H., Shaw G. M., Bubien J. K., Benveniste E. N. gp120-mediated alterations in astrocyte ion transport. Adv Neuroimmunol 1994b; 4: 175–179
  • Choi D. W. Excitotoxic cell death. J Neurobiol 1992; 23: 1261–1276
  • Dawson V. L., Dawson T. M., Uhl G. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993; 90: 3256–3259
  • Dewhurst S., Gelbard H. A., Fine S. M. Neuropathogenesis of AIDS. Mol Med Today 1996; 2: 16–23
  • Diop A. G., Lesort M., Esclaire F., Sindou P., Couratier P., Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci Lett 1994; 165: 187–190
  • Dreyer E. B., Kaiser P. K., Offermann J. T., Lipton S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990; 248: 364–367
  • Dreyer E. B., Lipton S. A. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur J Neurosci 1995; 7: 2502–2507
  • Elder J. H., Phillips T. R. Molecular properties of feline immunodeficiency virus (FIV). Infect Agents Dis 1993; 2: 361–374
  • Elder J. H., Schnolzer M., Cs H-L, Henson M., Lerner D. A., Phillips T. R., Wagaman P. C., Kent S. B. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J Virol 1993; 67: 1869–1876
  • Gendelman H. E., Lipton S. A., Tardieu M., Bukrinsky M. I., Nottet H. S. The neuropathogenesis of HIV-1 infection. J Leukoc Biol 1994; 56: 389–398
  • Genis P., Jett M., Bernton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y., Volsky D. J. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718
  • Giulian D., Baker T. J., Shih L. C., Lachman L. B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594–604
  • Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S. N., Schwarcz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 1996; 16: 3139–3153
  • Gray F., Haug H., Chimelli L., Geny C., Gaston A., Scaravilli F., Budka H. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol 1991; 82: 229–233
  • Grimaldi L. M., Martino G. V., Franciotta D. M., Brustia R., Castagna A., Pristera R., Lazzarin A. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991; 29: 21–25
  • Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluoresence properties. J Biol Chem 1985; 260: 3440–3450
  • Henriksen S. J., Prospero G. O., Phillips T. R., Fox H. S., Bloom F. E., Elder J. H. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. Curr Top Microbiol Immunol 1995; 202: 167–186
  • Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J. et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991; 29: 202–209
  • Holliday J., Gruol D. L. Cytokine stimulation increases intracellular calcium and alters the response to quisqualate in cultured cortical astrocytes. Brain Res 1993; 621: 233–241
  • Ikeda J., Terakawa S., Murota S., Morita I., Hirakawa K. Nuclear disintegration as a leading step of glutamate excitotoxicity in brain neurons. J Neurosci Res 1996; 43: 613–622
  • Jabbari B., Coats M., Salazar A., Martin A., Scherokman B., Lawa W. A. Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects. Electroencephalogr Clin Neurophysiol 1993; 86: 145–151
  • Lannuzel A., Lledo P. M., Lamghitnia H. O., Vincent J. D., Tardieu M. HIV-1 envelope proteins gp120 and gplBO potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci 1995; 7: 2285–2293
  • Lipton S. A. HIV-related neurotoxicity. Brain Pathol 1991; 1: 193–199
  • Lipton S. A. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 1992; 42: 1403–1405
  • Lipton S. A. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol 1994a; 8: 181–196
  • Lipton S. A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci 1994b; 16: 145–151
  • Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991; 7: 111–118
  • Lipton S. A., Yeh M., Dreyer E. B. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv Neuroimmunol 1994; 4: 181–188
  • Lo T. M., Fallert C. J., Piser T. M., Thayer S. A. HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res 1992; 594: 189–196
  • Mancuso V. A., Hope T. J., Zhu L., Derse D., Phillips T., Parslow T. G. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J Virol 1994; 68: 1998–2001
  • Meeker R. B., Thiede B. A., Hall C., English R., Tompkins M. Cortical cell loss in asymptomatic cats experimentally infected with feline immunodeficiency virus [In Process Citation]. Aids Res Hum Retroviruses 1997; 13: 1131–1140
  • Muller W. E., Schroder H. C., Ushijima H., Dapper J., Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 1992; 226: 209–214
  • Norman S. E., Chediak A. D., Freeman C., Kiel M., Mendez A., Duncan R., Simoneau J., Nolan B. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep 1992; 15: 150–155
  • Perovic S., Schleger C., Pergande G., Iskric S., Ushijima H., Rytik P., Muller W. E. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur J Pharmacol 1994; 288: 27–33
  • Peterson C., Neal J. H., Cotman C. W. Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons. Brain Res Dev Brain Res 1989; 48: 187–195
  • Phillips T. R., Lamont C., Konings D. A., Shacklett B. L., Hamson C. A., Luciw P. A., Elder J. H. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol 1992; 66: 5464–5471
  • Phillips T. R., Prospero G. O., Wheeler D. W., Wagaman P. C., Lerner D. L., Fox H. S., Whalen L. R., Bloom F. E., Elder J. H., Henriksen S. J. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neuroviral 1996; 2: 388–396
  • Phillips T. R., Prospero-Garcia O., Puaoi D. L., Lerner D. L., Fox H. S., Olmsted R. A., Bloom F. E., Henrikson S. J., Elder J. H. Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 1994; 75: 979–987
  • Phillips T. R., Talbott R. L., Lamont C., Muir S., Lovelace K., Elder J. H. Comparison of two host cell range variants of feline immunodeficiency virus. J Virol 1990; 64: 4605–4613
  • Podell M., Oglesbee M., Mathes L., Krakowka S., Olmstead R., Lafrado L. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J Acquir Immune Defic Syndr 1993; 6: 758–771
  • Power C., Moench T., Peeling J., Kong P. A., Langelier T. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997; 77: 1175–1185
  • Prospero-Garcia O., Herold N., Phillips T. R., Elder J. H., Bloom F. E., Henriksen S. J. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci USA 1994a; 91: 12947–12951
  • Prospero-Garcia O., Herold N., Waters A. K., Phillips T. R., Elder J. H., Henriksen S. J. Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res 1994b; 659: 254–258
  • Savio T., Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res 1993; 34: 265–272
  • Sindou P., Couratier P., Esclaire F., Yardin C., Bousseau A., Hugon J. Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole. J Neurol Sci 1994; 126: 133–137
  • Toggas S. M., Masliah E., Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996; 706: 303–307
  • Toggas S. M., Masliah E., Rockenstein E. M., Rail G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994; 367: 188–193
  • Trenkner E., Sturman J. A. The role of taurine in the survival and function of cerebellar cells in cultures of early postnatal cat. Int J Dev Neurosci 1991; 9: 77–88
  • Truckenmiller M. E., Kulaga H., Coggiano M., Wyatt R., Snyder S. H., Sweetnam P. M. Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system. Aids Res Hum Retroviruses 1993; 9: 445–453
  • Ushijima H., Ando S., Kunisada T., Schroder H. C., Klocking H. P., Kijjoa A., Muller W. E. HIV-1 gp120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures. J Acquir Immune Defic Syndr 1993; 6: 339–343
  • Wagaman P. C., Hasselkus L. C., Henson M., Lerner D. L., Phillips T. R., Elder J. H. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology 1993; 196: 451–457
  • Wickham T. J., Davis T., Granados R. R., Shuler M. L., Wood H. A. Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechol Prog 1992; 8: 391–396
  • Wickham T. J., Nemerow G. R. Optimization of growth methods and recombinant protein production in BTI-Tn-5B1–4 insect cells using the baculovirus expression system. Biotechnol Prog 1993; 9: 25–30
  • Yeung M. C., Pulliam L., Lau A. S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. Aids 1995; 9: 137–143
  • Yu N., Billaud J. N., Phillips T. R. Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci 1998; 95: 2624–2629

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.